
Euretos provides a data-driven platform for translational research, designed to empower researchers without requiring bioinformatics or data science expertise. The platform integrates a vast biological knowledge graph with literature, patents, and experimental, clinical, and real-world patient data. It offers a suite of applications, AI-powered predictive algorithms, and workflows that enable users to understand disease mechanisms, discover new drug targets, and assess pharmacological pathways. Euretos has a proven track record, with its platform and services contributing to approved drugs and active clinical trials across various therapeutic areas. Their business model appears to be SaaS and services, offering access to their platform and expert support to biopharma clients. The company is based in Leiden and Boston.

Euretos provides a data-driven platform for translational research, designed to empower researchers without requiring bioinformatics or data science expertise. The platform integrates a vast biological knowledge graph with literature, patents, and experimental, clinical, and real-world patient data. It offers a suite of applications, AI-powered predictive algorithms, and workflows that enable users to understand disease mechanisms, discover new drug targets, and assess pharmacological pathways. Euretos has a proven track record, with its platform and services contributing to approved drugs and active clinical trials across various therapeutic areas. Their business model appears to be SaaS and services, offering access to their platform and expert support to biopharma clients. The company is based in Leiden and Boston.